Manchester, MO, United States of America

Thomas C Riley

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 2.9

ph-index = 7

Forward Citations = 246(Granted Patents)


Location History:

  • Salem, NJ (US) (1984)
  • Manchester, MO (US) (1985 - 2017)

Company Filing History:


Years Active: 1984-2017

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Thomas C. Riley

Introduction

Thomas C. Riley is a notable inventor based in Manchester, Missouri. He has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His work focuses on developing innovative solutions for medical conditions, particularly those affecting women's health.

Latest Patents

One of his latest patents is a pharmaceutical delivery system designed to treat vaginal conditions in human patients. This formulation includes a delivery system that releases an active agent in a controlled manner for an extended period within the vaginal cavity. The system features an applicator composed of a high internal phase emulsion, which allows it to adhere to the mucosal surfaces of the body, primarily the lining of the vaginal cavity. Remarkably, this delivery system can maintain the high internal phase emulsion at a temperature of 86°F for at least one month without any decomposition or instability.

Career Highlights

Throughout his career, Thomas C. Riley has worked with several prominent companies, including K.V. Pharmaceutical Company and Drugtech Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Some of his notable coworkers include R. Saul Levinson and Robert C. Cuca. Their collaboration has likely played a role in advancing the projects they have worked on together.

Conclusion

Thomas C. Riley's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare solutions. His patents reflect a deep understanding of medical needs and a dedication to developing effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…